Free shipping on orders of $150 or more · Clinic & wholesale pricing available
TRYINSTAMED
Compounds · how to use CJC-1295

How to Use CJC-1295: What Labels and Clinics Say (and What We Won't Tell You)

A man in his mid-40s with natural realistic skin doing pull-ups on an outdoor park fitness bar, mid-motion, strong but natural build, wearing a pale mineral teal t-shirt, trees softly blurred behind
In this article
  1. The product: Strength, a two-peptide blend
  2. What the human research found
  3. Why the clinician referral is the grown-up answer
  4. The honest limits, once
  5. Who typically explores the Strength blend
  6. The bottom line

Short answer: CJC-1295 is not sold on its own here — it comes paired with Ipamorelin in the Strength strip. Using it is simple: one strip under the tongue, dissolve fully, swallow. The label states a five-days-on, two-days-off rhythm [brand claim — unverified]. Dose and suitability belong with a licensed clinician.

Most pages answering this query are forums repackaging injection protocols. This page does something more useful: it separates what's documented from what's folklore. Category background lives in the CJC-1295 / Ipamorelin pillar.

The product: Strength, a two-peptide blend

CJC-1295 is a long-acting analog of growth-hormone-releasing hormone; Ipamorelin is a selective growth hormone secretagogue — first characterized by Raun et al. (1998, PMID 9849822) as notable for releasing GH without significantly raising ACTH or cortisol in preclinical models [preclinical evidence]. The pairing is the classic "signal + pulse" combination, and the brand frames the Strength strip as supporting the body's natural growth hormone pathways tied to strength, stamina, and recovery [brand claim — unverified].

Per the panel: CJC-1295 250 mcg + Ipamorelin 250 mcg per strip, 20 strips, Citrus flavor. The label's stated usage rhythm — 5 days per week before bed or before a workout on an empty stomach, 2 days off, 12-week cycle described as optimal [brand claim — unverified] — is reported here as label text so you know what's printed on the box. The strip mechanics are format facts: place under the tongue, let it dissolve completely without chewing, then swallow. Delivery-science angle: sublingual CJC-1295.

What the human research found

The strongest human citation in this space is genuinely solid: Teichman et al., 2006 (Journal of Clinical Endocrinology & Metabolism, PMID 16352683) — two randomized, placebo-controlled, double-blind, ascending-dose trials in healthy adults using subcutaneous CJC-1295 (DAC form), reporting dose-dependent GH increases lasting six-plus days and IGF-I increases lasting 9–11 days after a single dose, with no serious adverse reactions at the studied doses [published human data]. A companion paper confirmed the body's natural GH pulsatility was preserved. That's a well-designed trial with encouraging tolerability — the reason researchers stay interested in this compound. It used injections under medical monitoring, which is why it informs the conversation rather than scripting your routine.

Why the clinician referral is the grown-up answer

Users frequently ask what clinic protocols look like for CJC-1295. Clinics that work with this compound operate under physician supervision, with intake labs and monitoring — the protocol is inseparable from that oversight. That's not a brush-off; it's how this category is done responsibly. Known and reported side-effect territory is covered factually in CJC-1295 side effects.

The honest limits, once

One passage, stated plainly: CJC-1295's regulatory file is unusually well documented, and you should know it. It was formerly in FDA's Category 2 ("substances that raise significant safety risks"), was removed when the nominations were withdrawn, and FDA then evaluated all five CJC-1295-related substances on its own initiative — at the December 4, 2024 Pharmacy Compounding Advisory Committee meeting, FDA proposed they not be added to the 503A Bulks List, citing limited clinical safety data. This is a compound whose federal record says the safety dossier is still thin; the full timeline is at is CJC-1295 legal in 2026. Regulatory positions in this space do get re-examined over time, and we'll keep that page current.

Who typically explores the Strength blend

The Strength strip draws people with structured training lives — the gym is already a habit, recovery is the bottleneck they're thinking about, and a needle-free strip fits a routine that injections never would. That "active lifestyle and recovery support" framing is the brand's [brand claim — unverified], and it's the honest way to think about the product: a consistency tool for people who already do the work.

The bottom line

If you're growth-hormone-pathway curious, the Strength blend is the needle-free, pre-dosed version of the most classic pairing in the category — CJC-1295 plus Ipamorelin — with real controlled-trial history behind the compounds and a label rhythm simple enough to actually keep. Strength is openly stocked at $145 per 20-strip box on the product page. Take the label to a licensed provider — ideally one who'll discuss the FDA record above — to decide together whether it belongs in your routine.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.

Reviewed by counsel against FDA structure/function guidance.

Questions

how to use CJC-1295 — quick answers

How do you use a CJC-1295 strip?

Mechanically: under the tongue, dissolve fully, no chewing, then swallow. The Strength label states a 5-days-on / 2-days-off rhythm, before bed or before a workout [brand claim — unverified] — reported as label text. Cadence and dose for you are clinician territory.

Is CJC-1295 sold by itself?

Not in the InstaMed line — it exists only combined with Ipamorelin in the Strength blend, 250 mcg of each per strip per the panel.

What did the FDA say about CJC-1295?

It was formerly Category 2 (the significant-safety-risk bucket), removed when nominations were withdrawn; FDA then evaluated it on its own initiative and at the December 4, 2024 PCAC meeting proposed that all five CJC-1295-related substances not be added to the 503A Bulks List.

Is CJC-1295 safe?

Controlled trials up to 49 days reported no serious adverse reactions at studied injected doses [published human data] — encouraging, and not the same as a long-term consumer safety profile. FDA evaluators cited limited clinical safety data. Talk to a licensed provider.

Educational content. This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.

FDA disclosure. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Newsletter

The honest peptide brief

One email a month: new research on the compounds we cover, new lots and COAs, and zero hype. Unsubscribe anytime.

We never sell your address. 18+ only.